These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9182722)

  • 1. Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.
    Haelewyn J; Michiels L; Verhaert P; Hoylaerts MF; Witters R; De Ley M
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):591-5. PubMed ID: 9182722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure/function studies on recombinant human gamma interferon.
    Fish EN; Banerjee K; Arakawa T; Stebbing N
    Drug Des Deliv; 1988 Feb; 2(3):191-206. PubMed ID: 2855574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-terminus of IFN gamma is sufficient for intracellular function.
    Szente BE; Soos JM; Johnson HW
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1645-54. PubMed ID: 7945313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids.
    Leinikki PO; Calderon J; Luquette MH; Schreiber RD
    J Immunol; 1987 Nov; 139(10):3360-6. PubMed ID: 2960733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of C-terminal processing on the activity of human interferon-gamma.
    Arakawa T; Narachi MA; Hsu YR; Everett RR; Lai PH; Fish EN
    Drug Des Deliv; 1989 May; 4(3):217-25. PubMed ID: 2518759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.
    Slodowski O; Böhm J; Schöne B; Otto B
    Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for agonist activity of a murine interferon-gamma peptide.
    Szente BE; Weiner IJ; Jablonsky MJ; Krishna NR; Torres BA; Johnson HM
    J Interferon Cytokine Res; 1996 Oct; 16(10):813-7. PubMed ID: 8910766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma.
    Magazine HI; Johnson HM
    Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
    Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
    J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation inactivation of human gamma-interferon: cellular activation requires two dimers.
    Langer JA; Rashidbaigi A; Garotta G; Kempner E
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5818-22. PubMed ID: 8016072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function.
    Szente BE; Johnson HM
    Biochem Biophys Res Commun; 1994 May; 201(1):215-21. PubMed ID: 8198577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.
    Nuara AA; Bai H; Chen N; Buller RM; Walter MR
    J Virol; 2006 Nov; 80(21):10675-82. PubMed ID: 16928759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of IFN-gamma receptor binding sites for JAK2 and enhancement of binding by IFN-gamma and its C-terminal peptide IFN-gamma(95-133).
    Szente BE; Subramaniam PS; Johnson HM
    J Immunol; 1995 Dec; 155(12):5617-22. PubMed ID: 7499845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation that decreases the thermal stability of human interferon gamma.
    Lunn CA; Fossetta J; Murgolo N; Zavodny PJ; Lundell D; Narula SK
    Protein Eng; 1992 Apr; 5(3):249-52. PubMed ID: 1409545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation of human interferon gamma abolishes receptor recognition.
    Lunn CA; Fossetta J; Dalgarno D; Murgolo N; Windsor W; Zavodny PJ; Narula SK; Lundell D
    Protein Eng; 1992 Apr; 5(3):253-7. PubMed ID: 1409546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity.
    Fountoulakis M; Lahm HW; Maris A; Friedlein A; Manneberg M; Stueber D; Garotta G
    J Biol Chem; 1991 Aug; 266(23):14970-7. PubMed ID: 1831199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton NMR sequence-specific assignments and secondary structure of a receptor binding domain of mouse gamma-interferon.
    Sakai TT; Jablonsky MJ; DeMuth PA; Krishna NR; Jarpe MA; Johnson HM
    Biochemistry; 1993 Jun; 32(21):5650-5. PubMed ID: 8504085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma variants with deletions in the AB surface loop--flexibility is a critical point for receptor binding.
    Waschütza G; Dengler U; Villmann C; Böttinger H; Otto B
    Eur J Biochem; 1998 Sep; 256(2):303-9. PubMed ID: 9760168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant chicken IFN-gamma expressed in Escherichia coli: analysis of C-terminal truncation and effect on biologic activity.
    Michalski WP; Shiell BJ; O'Neil TE; Beddome G; Lowenthal JW
    J Interferon Cytokine Res; 1999 Apr; 19(4):383-92. PubMed ID: 10334390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing affinity of interferon-γ receptor 1 to interferon-γ by computer-aided design.
    Mikulecký P; Cerný J; Biedermannová L; Petroková H; Kuchař M; Vondrášek J; Malý P; Šebo P; Schneider B
    Biomed Res Int; 2013; 2013():752514. PubMed ID: 24199198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.